Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
Julien Cherfils-Vicini, … , Catherine Sautès-Fridman, Isabelle Cremer
Julien Cherfils-Vicini, … , Catherine Sautès-Fridman, Isabelle Cremer
Published March 8, 2010
Citation Information: J Clin Invest. 2010;120(4):1285-1297. https://doi.org/10.1172/JCI36551.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 9

Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance

  • Text
  • PDF
Abstract

Compelling evidence suggests that inflammation, cell survival, and cancer are linked, with a central role played by NF-κB. Recent studies implicate some TLRs in tumor development based on their ability to facilitate tumor growth; however, to our knowledge, involvement of neither TLR7 nor TLR78 has yet been demonstrated. Here we have demonstrated expression of TLR7 and TLR8, the natural receptors for single-stranded RNA, by tumor cells in human lung cancer in situ and in human lung tumor cell lines. Stimulation with TLR7 or TLR8 agonists led to activated NF-κB, upregulated expression of the antiapoptotic protein Bcl-2, increased tumor cell survival, and chemoresistance. Transcriptional analysis performed on human primary lung tumor cells and TLR7- or TLR8-stimulated human lung tumor cell lines revealed a gene expression signature suggestive of chronic stimulation of tumor cells by TLR ligands in situ. Together, these data emphasize that TLR signaling can directly favor tumor development and further suggest that researchers developing anticancer immunotherapy using TLR7 or TLR8 agonists as adjuvants should take into account the expression of these TLRs in lung tumor cells.

Authors

Julien Cherfils-Vicini, Sophia Platonova, Mélanie Gillard, Ludivine Laurans, Pierre Validire, Rafaele Caliandro, Pierre Magdeleinat, Fathia Mami-Chouaib, Marie-Caroline Dieu-Nosjean, Wolf-Herman Fridman, Diane Damotte, Catherine Sautès-Fridman, Isabelle Cremer

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 Total
Citations: 3 6 7 7 7 8 4 8 9 8 7 8 7 11 6 1 107
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (107)

Title and authors Publication Year
Toll-Like Receptor 4 and 8 are Overexpressed in Lung Biopsies of Human Non-small Cell Lung Carcinoma
Ceccarelli S, Pasqua Marzolesi V, Vannucci J, Bellezza G, Floridi C, Nocentini G, Cari L, Traina G, Petri D, Puma F, Conte C
Lung 2025
Retroelement co-option disrupts the cancer transcriptional programme
Loong J, Thompson R, Hall C, Doglio L, Pape J, Plowman T, Kassiotis G
Genome Medicine 2025
Involvement of nucleic acid-sensing toll-like receptors in human diseases and their controlling mechanisms
Lin YS, Chang YC, Pu TY, Chuang TH, Hsu LC
Journal of Biomedical Science 2025
Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironment
Gupta KH, Giurini EF, Zloza A
Frontiers in Oncology 2024
Toll-like receptors 1–9 in small bowel neuroendocrine tumors–Clinical significance and prognosis
Hiltunen N, Kemi N, Väyrynen JP, Böhm J, Kauppila JH, Huhta H, Helminen O
PloS one 2024
The Novel Fusion Protein Melittin‐MIL‐2 Exhibits Strong Antitumor Immune Effect in Lung Adenocarcinoma Cell A549
Gao W, Li W, Wang Z, Li Y, Liu M
The Clinical Respiratory Journal 2024
Rice Husk Silica Liquid Enhances Autophagy and Reduces Overactive Immune Responses via TLR-7 Signaling in Lupus-Prone Models
Kao C, Wang SW, Chen PC, Huang CY, Wei YF, Ho CH, Hong YH
International Journal of Molecular Sciences 2024
Impact of TLR9 and TLR7 gene polymorphisms on prognosis and survival of patients with oral squamous cell carcinoma
Obrenović M, Šupić G, Miyabe S, Mladenović I, Kozomara R, Jović S, Ćurčin AP, Štefik D, Stosić S, Ðurđević BV
Biomolecules and Biomedicine 2024
TLR7 Promotes Acute Inflammatory-Driven Lung Dysfunction in Influenza-Infected Mice but Prevents Late Airway Hyperresponsiveness
Miles MA, Liong S, Liong F, Trollope GS, Wang H, Brooks RD, Bozinovski S, O\u2019Leary JJ, Brooks DA, Selemidis S
International Journal of Molecular Sciences 2024
A new immune signature for survival prediction and immune checkpoint molecules in non-small cell lung cancer
Han S, Jiang D, Zhang F, Li K, Jiao K, Hu J, Song H, Ma QY, Wang J
Frontiers in Oncology 2023
Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities.
Haroun R, Naasri S, Oweida AJ
Human vaccines 2023
TLRs: Innate Immune Sentries against SARS-CoV-2 Infection
Mantovani S, Oliviero B, Varchetta S, Renieri A, Mondelli MU
International journal of molecular sciences 2023
β-arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4.
Kim JY, Shin JH, Kim MJ, Kang Y, Lee JS, Son J, Jeong SK, Kim D, Kim DH, Chun E, Lee KY
Cell Death and Disease 2023
Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
Ying J, Hong H, Yu C, Jiang M, Ding D
Medicine 2023
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Mukherjee S, Patra R, Behzadi P, Masotti A, Paolini A, Sarshar M
Frontiers in immunology 2023
Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis
Giriyappagoudar M, Vastrad B, Horakeri R, Vastrad C
Biomedicines 2023
TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer
Martín-Medina A, Cerón-Pisa N, Martinez-Font E, Shafiek H, Obrador-Hevia A, Sauleda J, Iglesias A
International journal of molecular sciences 2022
The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer
Zhou J, Xu Y, Wang G, Mei T, Yang H, Liu Y
International journal of oncology 2022
Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression
Giurini EF, Madonna MB, Zloza A, Gupta KH
Cancers 2022
Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
Andón FT, Leon S, Ummarino A, Redin E, Allavena P, Serrano D, Anfray C, Calvo A
Biomedicines 2022
Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy
Hoden B, DeRubeis D, Martinez-Moczygemba M, Ramos KS, Zhang D
Frontiers in immunology 2022
At the crux of maternal immune activation: Viruses, microglia, microbes, and IL‐17A
Otero AM, Antonson AM
Immunological Reviews 2022
The Role of Nucleases Cleaving TLR3, TLR7/8 and TLR9 Ligands, Dicer RNase and miRNA/piRNA Proteins in Functional Adaptation to the Immune Escape and Xenophagy of Prostate Cancer Tissue
Kocic G, Hadzi-Djokic J, Colic M, Veljkovic A, Tomovic K, Roumeliotis S, Smelcerovic A, Liakopoulos V
International journal of molecular sciences 2022
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
S Cuzzubbo, S Mangsbo, D Nagarajan, K Habra, AG Pockley, SE McArdle
Frontiers in immunology 2021
A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1
D Shah, A Comba, SM Faisal, P Kadiyala, GJ Baker, MS Alghamri, R Doherty, D Zamler, G Nuñez, MG Castro, PR Lowenstein
OncoImmunology 2021
A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer
V Branchi, L Esser, C Boden, A Jafari, J Henn, P Lingohr, MA Gonzalez-Carmona, M Schmitz, TJ Weismüller, CP Strassburg, S Manekeller, G Kristiansen, JC Kalff, H Matthaei, MI Toma
Diagnostics 2021
Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy
S Baglivo, F Bianconi, G Metro, A Gili, FR Tofanetti, G Bellezza, B Ricciuti, M Mandarano, V Teti, A Siggillino, MS Reda, R Chiari, L Pistola, A Sidoni, V Minotti, F Roila, V Ludovini
Genes & development 2021
Toll-Like Receptor 7 Mediates Inflammation Resolution and Inhibition of Angiogenesis in Non-Small Cell Lung Cancer
F Liotti, M Marotta, D Sorriento, E Pone, F Morra, RM Melillo, N Prevete
Cancers 2021
Urban air PM modifies differently immune defense responses against bacterial and viral infections in vitro
MA Shahbaz, MV Martikainen, TJ Rönkkö, M Komppula, PI Jalava, M Roponen
Environmental Research 2021
Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma
LL Lin, ZZ Liu, JZ Tian, X Zhang, Y Zhang, M Yang, HC Zhong, W Fang, RX Wei, C Hu
Frontiers in Oncology 2021
Toll-like Receptors from the Perspective of Cancer Treatment
N Javaid, S Choi
Cancers 2020
Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence
SD Gowing, JJ Cool-Lartigue, JD Spicer, AJ Seely, LE Ferri
Clinical & Experimental Metastasis 2020
Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
C Patinote, NB Karroum, G Moarbess, N Cirnat, I Kassab, PA Bonnet, C Deleuze-Masquéfa
European Journal of Medicinal Chemistry 2020
Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions
D Dutta, SH Lim
Biomarker Research 2020
Toll‐like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis
Y Mokhtari, A PourbagheriSigaroodi, P Zafari, N Bagheri, SH Ghaffari, D Bashash
Journal of Cellular and Molecular Medicine 2020
Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma
W Li, LN Gao, PP Song, CG You
Aging 2020
Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers
X Liu, Q Xu, Z Li, B Xiong
Scientific Reports 2020
Impact of Genetic Variation in TLR4 3′UTR on NSCLC Genetic Susceptibility
H Wu, H Gao, A Li, Y Xie, Z Jia, Z Yang, H Zhang, Z Zhang, X Zhang
Journal of Oncology 2020
TLRs in pulmonary diseases
S Arora, S Ahmad, R Irshad, Y Goyal, S Rafat, N Siddiqui, K Dev, M Husain, S Ali, A Mohan, MA Syed
Life Sciences 2019
Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
Javaid, Yasmeen, Choi
Pharmaceutics 2019
Novel Insights reveal Anti-microbial Gene Regulation of Piglet Intestine Immune in response to Clostridium perfringens Infection
XY Huang, WY Sun, ZQ Yan, HR Shi, QL Yang, PF Wang, SG Li, LX Liu, SG Zhao, SB Gun
Scientific Reports 2019
Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection
M Aleynick, J Svensson-Arvelund, CR Flowers, A Marabelle, JD Brody
Clinical cancer research 2019
TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
L Huang, H Xu, G Peng
Cellular and Molecular Immunology 2018
Inflammation and pancreatic cancer: An updated review
K Shadhu,
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 2018
Targeting Toll-Like Receptors for Cancer Therapy
MJ Braunstein, J Kucharczyk, S Adams
Targeted Oncology 2018
Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
BR Huck, L Kötzner, K Urbahns
Angewandte Chemie (International ed. in English) 2018
Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist
T Hosoya, F Sato-Kaneko, A Ahmadi, S Yao, F Lao, K Kitaura, T Matsutani, DA Carson, T Hayashi
Proceedings of the National Academy of Sciences 2018
Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer
M Sun, Y Bai, S Zhao, X Liu, Y Gao, L Wang, B Liu, D Ma, C Ma
Oncotarget 2018
Linking common non-coding RNAs of human lung cancer and M. tuberculosis
D Barh, S Tiwari, RN Kumavath, P Ghosh, V Azevedo
Bioinformation 2018
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
M Dajon, K Iribarren, F Petitprez, S Marmier, A Lupo, M Gillard, H Ouakrim, N Victor, DB Vincenzo, PE Joubert, O Kepp, G Kroemer, M Alifano, D Damotte, I Cremer
OncoImmunology 2018
MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer
A Bouillez, H Rajabi, C Jin, M Samur, A Tagde, M Alam, M Hiraki, T Maeda, X Hu, D Adeegbe, S Kharbanda, KK Wong, D Kufe
Oncogene 2017
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth
JC Klein, K Moses, G Zelinskyy, S Sody, J Buer, S Lang, I Helfrich, U Dittmer, CJ Kirschning, S Brandau
Nature Communications 2017
Anti-tumor Activity of Toll-Like Receptor 7 Agonists
H Chi, C Li, FS Zhao, L Zhang, TB Ng, G Jin, O Sha
Frontiers in pharmacology 2017
Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer: Predictive value of TLR7 polymorphism for cetuximab
S Okazaki, S Stintzing, Y Sunakawa, S Cao, W Zhang, D Yang, Y Ning, S Matsusaka, MD Berger, Y Miyamoto, M Suenaga, M Schirripa, JD West, R Gopez, T Akihito, W Ichikawa, V Heinemann, RW DePaolo, HJ Lenz
International Journal of Cancer 2017
Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer
CB Chesson, A Zloza
Nanomedicine 2017
Toll-like receptor expression in human non-small cell lung carcinoma: potential prognostic indicators of disease
AK Bauer, BL Upham, EA Rondini, MA Tennis, K Velmuragan, D Wiese
Oncotarget 2017
Roles of toll-like receptors: From inflammation to lung cancer progression (Review)
J Gu, Y Liu, B Xie, P Ye, J Huang, Z Lu
Biomedical Reports 2017
A Systems Biology Approach Provides Deeper Insights into Differentially Expressed Genes in Taxane-Anthracycline Chemoresistant and Non-Resistant Breast Cancers
Shamim Sarhadi, Somayeh Sadeghi, Fatemeh Nikmanesh, Younes Pilehvar Soltanahmadi, Arman Shahabi, Sedigheh Fekri Aval, Nosratollah Zarghami
Asian Pacific Journal of Cancer Prevention 2017
Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients
Jouhi L, Mohamed H, Mäkitie A, Remes SM, Haglund C, Atula T, Hagström J
Cancer Immunology, Immunotherapy 2017
Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis
M Liu, X Zeng, J Wang, Z Fu, J Wang, M Liu, D Ren, B Yu, L Zheng, X Hu, W Shi, J Xu
Stem Cell Research & Therapy 2016
The Role of Toll-Like Receptors in Hematopoietic Malignancies
DA Monlish, ST Bhatt, LG Schuettpelz
Frontiers in immunology 2016
Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling
DW Yeh, LR Huang, YW Chen, CY Huang, TH Chuang
Journal of Immunology Research 2016
Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells
J Jiang, L Dong, B Qin, H Shi, X Guo, Y Wang
Oncology Letters 2016
Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab
S Okazaki, F Loupakis, S Stintzing, S Cao, W Zhang, D Yang, Y Ning, Y Sunakawa, S Stremitzer, S Matsusaka, MD Berger, A Parekh, JD West, Y Miyamoto, M Suenaga, M Schirripa, C Cremolini, A Falcone, V Heinemann, RW DePaolo, HJ Lenz
Molecular cancer therapeutics 2016
Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer
T Grimmig, R Moench, J Kreckel, S Haack, F Rueckert, R Rehder, S Tripathi, C Ribas, A Chandraker, C Germer, M Gasser, A Waaga-Gasser
International journal of molecular sciences 2016
Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses
C Hotz, M Treinies, I Mottas, LC Rötzer, A Oberson, L Spagnuolo, M Perdicchio, T Spinetti, T Herbst, C Bourquin
OncoImmunology 2016
Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination
YK Jeon, CK Kim, J Koh, DH Chung, GH Ha
Oncotarget 2016
Dual roles of TLR7 in the lung cancer microenvironment
M Dajon, K Irribarren, I Cremer
OncoImmunology 2015
Radiation takes its Toll
JA Ratikan, ED Micewicz, MW Xie, D Schaue
Cancer Letters 2015
Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma—an in vivo and in vitro study
L Jouhi, N Datta, S Renkonen, T Atula, A Mäkitie, C Haglund, A Ahmed, S Syrjänen, R Grénman, E Auvinen, S Lehtonen, J Hagström
Tumor Biology 2015
Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation
DS Yu, CL Wu, SY Ping, C Keng, KH Shen
The Kaohsiung Journal of Medical Sciences 2015
TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer
T Grimmig, N Matthes, K Hoeland, S Tripathi, A Chandraker, M Grimm, R Moench, EM Moll, H Friess, I Tsaur, R Blaheta, C Germer, A Waaga-Gasser, M Gasser
International journal of oncology 2015
Gonadotropin-mediated chemoresistance: Delineation of molecular pathways and targets
S Sahoo, P Singh, B Kalha, O Singh, R Pal
BMC Cancer 2015
[Expression of TLR5 in different types of non-small cell lung cancer cell lines and its activation mechanism]
Hui Zhou, Mei Luo, Yige Wen, Andi Ma, Yongzhong Luo, Qing Yi, Jianhua Chen, Ling Xiao
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2015
TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence
J Ye, C Ma, EC Hsueh, J Dou, W Mo, S Liu, B Han, Y Huang, Y Zhang, MA Varvares, DF Hoft, G Peng
EMBO Molecular Medicine 2014
Transient receptor potential ankyrin 1 receptor activation in vitro and in vivo by pro-tussive agents: GRC 17536 as a promising anti-tussive therapeutic
I Mukhopadhyay, A Kulkarni, S Aranake, P Karnik, M Shetty, S Thorat, I Ghosh, D Wale, V Bhosale, N Khairatkar-Joshi
PloS one 2014
Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest
I Gañán-Gómez, Y Wei, H Yang, S Pierce, C Bueso-Ramos, G Calin, MD Boyano-Adánez, G García-Manero
PloS one 2014
High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer
H Zhou, J Chen, J Hu, Y Luo, F Li, L Xiao, M Zhong
Journal of Cancer Research and Clinical Oncology 2014
The expression of Toll-like receptor 8 and its relationship with VEGF and Bcl-2 in cervical cancer
Y Zhang, H Yang, PA Barnie, P Yang, Z Su, J Chen, Z Jiao, L Lu, S Wang, H Xu
International journal of medical sciences 2014
Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
S Deng, S Zhu, Y Qiao, YJ Liu, W Chen, G Zhao, J Chen
Protein & Cell 2014
Classification of current anticancer immunotherapies
Galluzzi L, Vacchelli E, Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G
Oncotarget 2014
Targeting the tumor microenvironment to enhance antitumor immune responses
Van der Jeught K, Bialkowski L, Daszkiewicz L, Broos K, Goyvaerts C, Renmans D, Van Lint S, Heirman C, Thielemans K, Breckpot K
Oncotarget 2014
TLR agonists: our best frenemy in cancer immunotherapy
S Kaczanowska, AM Joseph, E Davila
Journal of leukocyte biology 2013
The Yin and Yang of Toll-like receptors in cancer
JP Pradere, DH Dapito, RF Schwabe
Oncogene 2013
Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination
Z Zhan, X Xie, H Cao, X Zhou, XD Zhang, H Fan, Z Liu
Autophagy 2013
Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation
O Koltsida, S Karamnov, K Pyrillou, T Vickery, AD Chairakaki, C Tamvakopoulos, P Sideras, CN Serhan, E Andreakos
EMBO Molecular Medicine 2013
A new role for microRNAs, as ligands of Toll-like receptors
M Fabbri, A Paone, F Calore, R Galli, CM Croce
RNA biology 2013
Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy
YC Chen, CC Hsiao, KD Chen, YC Hung, CY Wu, CH Lie, SF Liu, MT Sung, CJ Chen, TY Wang, JC Chang, P Tang, WF Fang, YH Wang, YH Chung, TY Chao, SY Leung, MC Su, CC Wang, MC Lin
PloS one 2013
Toll-like receptor-2/6 and Toll-like receptor-9 agonists suppress viral replication but not airway hyperreactivity in guinea pigs
MG Drake, SE Evans, BF Dickey, AD Fryer, DB Jacoby
American journal of respiratory cell and molecular biology 2013
Toll-Like Receptor 7 Regulates Pancreatic Carcinogenesis
Atsuo Ochi, Christopher Graffeo, Constantinos Zambirinis, Adeel Rehman, Michael Hackman, Nina Fallon, Rocky Barilla, Justin Henning, Mohsin Jamal, Raghavendra Rao, Stephanie Greco, Michael Deutsch, Marco Medina-Zea, Usama Bin Saeed, Melvin Ego-Osuala, Cristina Hajdu, George Miller
Journal of Clinical Investigation 2012
Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling
V Gosu, S Basith, OP Kwon, S Choi
Molecules (Basel, Switzerland) 2012
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
H Pere, C Tanchot, J Bayry, M Terme, J Taieb, C Badoual, O Adotevi, N Merillon, E Marcheteau, VR Quillien, C Banissi, A Carpentier, F Sandoval, M Nizard, F Quintin-Colonna, G Kroemer, WH Fridman, L Zitvogel, SP Oudard, E Tartour
OncoImmunology 2012
Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation
A Stathopoulos, C Pretto, L Devillers, D Pierre, FM Hofman, C Kruse, M Jadus, TC Chen, VE Schijns
OncoImmunology 2012
TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity
F Riva, E Bonavita, E Barbati, M Muzio, A Mantovani, C Garlanda
Frontiers in immunology 2012
Trial Watch
L Galluzzi, E Vacchelli, A Eggermont, WH Fridman, J Galon, C Sautès-Fridman, E Tartour, L Zitvogel, G Kroemer
OncoImmunology 2012
Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
M Muccioli, L Sprague, H Nandigam, M Pate, F Benencia
ISRN Oncology 2012
Silencing of Renal DNaseI in Murine Lupus Nephritis Imposes Exposure of Large Chromatin Fragments and Activation of Toll Like Receptors and the Clec4e
D Thiyagarajan, S Fismen, N Seredkina, S Jacobsen, T Elung-Jensen, AL Kamper, CG Fenton, OP Rekvig, ES Mortensen
PloS one 2012
Immunogenic cell death and DAMPs in cancer therapy
DV Krysko, AD Garg, A Kaczmarek, O Krysko, P Agostinis, P Vandenabeele
Nature Reviews Cancer 2012
Targeting pattern recognition receptors in cancer immunotherapy
N Goutagny, Y Estornes, U Hasan, S Lebecque, C Caux
Targeted Oncology 2012
The Therapeutic Potential of Toll-like Receptor 7 Stimulation in Asthma
Drake MG, Kaufman EH, Fryer AD, Jacoby DB
Inflammation & allergy drug targets 2012
The Toll-like receptor gene family is integrated into human DNA damage and p53 networks
D Menendez, M Shatz, K Azzam, S Garantziotis, MB Fessler, MA Resnick
PLoS genetics 2011
Lung cancer and Toll-like receptors
A Pinto, S Morello, R Sorrentino
Cancer Immunology, Immunotherapy 2011
Alterations in the expression of genes related to NF-κB signaling in liver and kidney of CuZnSOD-deficient mice
K Brzóska, B Sochanowicz, A Siomek, R Oliński, M Kruszewski
Molecular and Cellular Biochemistry 2011
Bacterial immunotherapy of gastrointestinal tumors
M Linnebacher, C Maletzki, U Klier, E Klar
Langenbeck's Archives of Surgery 2011
Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma
I Sheyhidin, G Nabi, A Hasim, RP Zhang, J Ainiwaer, H Ma, H Wang
World journal of gastroenterology : WJG 2011
Update in Lung Cancer and Oncological Disorders 2010
B Halmos, CA Powell
American journal of respiratory and critical care medicine 2011
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 22 patents
164 readers on Mendeley
See more details